Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008) - Digest Version

被引：115

作者：

Ogawa, Satoshi ^{[1
]}

Aizawa, Yoshifusa ^{[3
]}

Atarashi, Hirotsugu ^{[2
]}

Inoue, Hiroshi ^{[4
]}

Kamakura, Shiro ^{[5
]}

Koretsune, Yukihiro ^{[6
]}

Kumagai, Koichiro ^{[7
]}

Mitamura, Hideo ^{[8
]}

Okumura, Ken ^{[9
]}

Sugi, Kaoru ^{[10
]}

Yamashita, Takeshi ^{[11
]}

Yasaka, Masahiro ^{[12
]}

Hiejima, Kazumasa ^{[13
]}

Kodama, Itsuo ^{[14
]}

Ohe, Tohru ^{[15
]}

Yano, Katsusuke ^{[16
]}

机构：

[1] Int Univ Hlth & Welf, Mita Hosp, Tokyo, Japan

[2] Tama Nagayama Hosp, Nippon Med Sch, Tokyo, Japan

[3] Niigata Univ, Grad Sch Med & Dent Sci, Div Cardiol, Niigata 95021, Japan

[4] Toyama Univ, Dept Internal Med 2, Toyama, Japan

[5] Natl Cardiovasc Ctr Hosp & Res Inst, Div Cardiol, Suita, Osaka, Japan

[6] Natl Hosp Org Osaka Med Ctr, Inst Clin Res, Osaka, Japan

[7] Fukuoka Sanno Hosp, Heart Rhythm Ctr, Fukuoka, Japan

[8] Tokyo Saiseikai Cent Hosp, Tokyo, Japan

[9] Hirosaki Univ, Grad Sch Med, Dept Cardiol Resp Med & Nephrol, Hirosaki, Aomori, Japan

[10] Toho Univ, Div Cardiovasc Med, Ohashi Med Ctr, Tokyo, Japan

[11] Cardiovasc Inst Hosp, Dept Cardiol, Tokyo, Japan

[12] Natl Hosp Org Kyushu Med Ctr, Dept Cerebrovasc Dis, Fukuoka, Japan

[13] Kudanzaka Hosp, Tokyo, Japan

[14] Sakakibara Heart Inst Okayama, Okayama, Japan

[15] Nagasaki Int Univ, Fac Hlth Management, Nagasaki, Japan

[16] Nagoya Univ, Res Inst Environm Med, Dept Cardiovasc Res, Nagoya, Aichi, Japan

来源：

CIRCULATION JOURNAL | 2010年 / 74卷 / 11期

关键词：

ANGIOTENSIN-CONVERTING ENZYME; PROTHROMBIN COMPLEX CONCENTRATE; PILSICAINIDE SUPPRESSION TRIAL; HEART RHYTHM ASSOCIATION; MAINTAIN SINUS RHYTHM; PULMONARY VEINS; THROMBOEMBOLIC EVENTS; CATHETER ABLATION; RISK-FACTORS; FOLLOW-UP;

D O I：

10.1253/circj.CJ-88-0001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2479 / 2500

页数：22

共 173 条

[51] Classification of atrial fibrillation [J].

Gallagher, MM ;

Camm, AJ .

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1997, 20 (06) :1603-1605

[52] Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled study [J].

Galve, E ;

Rius, T ;

Ballester, R ;

Artaza, MA ;

Arnau, JM ;

GarciaDorado, D ;

SolerSoler, J .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (05) :1079-1082

[53] Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study [J].

Go, AS ;

Hylek, EM ;

Phillips, KA ;

Chang, YC ;

Henault, LE ;

Selby, JV ;

Singer, DE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18) :2370-2375

[54] Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation [J].

Goette, A ;

Staack, T ;

Röcken, C ;

Arndt, M ;

Geller, JC ;

Huth, C ;

Ansorge, S ;

Klein, HU ;

Lendeckel, U .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (06) :1669-1677

[55] Maintenance of sinus rhythm in patients with atrial fibrillation - An AFFIRM substudy of the first antiarrhythmic drug [J].

Greene, HL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) :20-29

[56]

Hagens VE, 2002, CIRCULATION, V106, P634

[57] Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins [J].

Haïssaguerre, M ;

Jaïs, P ;

Shah, DC ;

Takahashi, A ;

Hocini, M ;

Quiniou, G ;

Garrigue, S ;

Le Mouroux, A ;

Le Métayer, P ;

Clémenty, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (10) :659-666

[58] COMPARISON OF SOTALOL WITH DIGOXIN-QUINIDINE FOR CONVERSION OF ACUTE ATRIAL-FIBRILLATION TO SINUS RHYTHM (THE SOTALOL-DIGOXIN-QUINIDINE TRIAL) [J].

HALINEN, MO ;

HUTTUNEN, M ;

PAAKKINEN, S ;

TARSSANEN, L .

AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (07) :495-498

[59] Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V) [J].

Halperin, JL .

AMERICAN HEART JOURNAL, 2003, 146 (03) :431-438

[60] Class Ia antiarrhythmic drug cibenzoline - A new approach to the medical treatment of hypertrophic obstructive cardiomyopathy [J].

Hamada, M ;

Shigematsu, Y ;

Ikeda, S ;

Hara, Y ;

Okayama, H ;

Kodama, K ;

Ochi, T ;

Hiwada, K .

CIRCULATION, 1997, 96 (05) :1520-1524

← 1 2 3 4 5 6 7 8 9 10 →